Android Artificial Pancreas System (Android APS) Versus Control-IQ (CODIAC)

Charles University, Czech Republic

Status: Unknown

Conditions: Diabetes Mellitus, Type 1

Treatments: Device: Insulin Pump t:slim X2 with Control-IQ technology

Study type: Interventional

Funder types: Other

Identifiers

NCT05165615

CODIAC

Details and patient eligibility

About

The aim of the investigator's study is to compare two different closed loop hybrid systems - certified Control-IQ and noncertified AndroidAPS in adult patients with Type 1 Diabetes (T1D), who had been using AndroidAPS previously from their own decision, during 12 weeks of follow-up.

Enrollment: 20 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 1 diabetes diagnosed >2 years
• ≥ 18 years old
• written informed consent prior to starting study related activity
• previous user of AndroidAPS at least for 3 months

Exclusion criteria

• severe noncompliance
• lactation, pregnancy, intending to become pregnant during study
• use of medication with effects on carbohydrate metabolism

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

AndroidAPS versus Control-IQ

Experimental group

Description:

Patients with use of the Control-IQ system (closed-loop hybrid system) and previous users of AndroidAPS (closed-loop hybrid system)

Treatment:

Device: Insulin Pump t:slim X2 with Control-IQ technology